Search Results
Apr 01, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky
April 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action.
More news about: Levi & Korsinsky, LLP
Mar 31, 2026, 15:22 ET BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline.So what: If
More news about: THE ROSEN LAW FIRM, P. A.
Mar 31, 2026, 12:00 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BSX) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 31, 2026, 09:00 ET BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm
March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX).
More news about: The Gross Law Firm
Mar 30, 2026, 08:00 ET Boston Scientific announces conference call discussing first quarter 2026 results
MARLBOROUGH, Mass., March 30, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2026, on Wednesday, April
More news about: Boston Scientific Corporation
Mar 30, 2026, 06:45 ET Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System
MARLBOROUGH, Mass., March 30, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Asurys™ Fluid Management System, designed to provide irrigation and
More news about: Boston Scientific Corporation
Mar 29, 2026, 08:46 ET BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
national securities law firm, is investigating potential claims against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX) and reminds investors of the May 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 28, 2026, 10:55 ET CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN
More news about: Boston Scientific Corporation
Mar 28, 2026, 10:38 ET HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive data from the HI-PEITHO global randomized clinical trial evaluating the use of the EKOS™ Endovascular System in patients with
More news about: Boston Scientific Corporation
Mar 27, 2026, 15:21 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BSX).
More news about: Glancy Prongay Wolke & Rotter LLP
Mar 26, 2026, 17:58 ET BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline.So what: If
More news about: THE ROSEN LAW FIRM, P. A.
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-boston-scientific-corporation-of-class-action-lawsuit-and-upcoming-deadlines--bsx-302725666.htmlSOURCE
More news about: Pomerantz LLP
Mar 26, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth: SueWallSt
March 26, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Boston Scientific Corporation (NYSE: BSX) to contact the firm. Those who purchased BSX securities between July 23, 2025, and February 3, 2026, may be entitled to recover damages.
More news about: SueWallSt.com
Mar 25, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky
March 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 09:00 ET BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
March 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX).
More news about: The Gross Law Firm
Mar 23, 2026, 22:33 ET Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action
LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026. Boston Scientific is a global company that develops, manufactures, and markets medical devices
More news about: Robbins LLP
Mar 20, 2026, 16:07 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BSX). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BOSTON SCIENTIFIC CORPORATION (BSX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MAY 4, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Mar 19, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-boston-scientific-corporation-of-class-action-lawsuit-and-upcoming-deadlines--bsx-302718406.htmlSOURCE
More news about: Pomerantz LLP
Mar 19, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt
YORK, March 19, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Boston Scientific
More news about: SueWallSt.com
Mar 18, 2026, 09:00 ET BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Claims Executives Misrepresented U.S. Electrophysiology Volumes: Levi & Korsinsky
March 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action.
More news about: Levi & Korsinsky, LLP
Mar 17, 2026, 15:50 ET Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BSX) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 17, 2026, 09:00 ET BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm
March 17, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Boston Scientific Corporation (NYSE: BSX).
More news about: The Gross Law Firm
Mar 16, 2026, 22:00 ET BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline.So what: If
More news about: THE ROSEN LAW FIRM, P. A.
Mar 16, 2026, 14:54 ET BSX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
national securities law firm, is investigating potential claims against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX) and reminds investors of the May 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 12, 2026, 19:25 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX
Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are advised to contact Danielle Peyton at [email protected]
More news about: Pomerantz LLP